You may also like
The Pulse on Perfusion: Simulation, Animal Testing, and the Future of Training
As 2026 continues to bring rapid advances in technology, this month’s Pulse on Perfusion turns to a question many in the field are actively grappling with: how far can simulation go, and where do animal models still play a role? At Perfusion.com, this poll explores the intersection of ethics, education, and clinical readiness – areas where decisions are rarely simple and often deeply personal. With many perfusionists having trained on animal models themselves, the responses reflect not just opinions but lived experience. What emerges is a thoughtful and at times divided conversation about what the future of perfusion training should look like.
6 min read
Clinical and Hematological Outcomes of Aminocaproic Acid Use During Pediatric Cardiac ECMO
ACA administration was not associated with specific adverse effects. A clinically significant reduction in bleeding amount, red blood cell transfusions, and other hematologic interventions occurred following ACA administration for pediatric patients on ECMO. Wider consideration for ACA use as a part of a multipronged strategy to manage bleeding during ECMO should be considered.
1 min read
Superior Myocardial Protection Using “Polarizing” Adenosine, Lidocaine, and Mg2+ Cardioplegia in Humans
Myocardial protection with current methods of cardioplegia is still incomplete (1–3).
1 min read